It is known that during cancer progression, bone marrow-derived HSPCs commit preferentially towards immunosuppressive lineages such as MDSCs induced by the tumor-derived cytokines granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF)77. Here, CSF2 is linked to cancer.